Why the study?
Can a simple clinical scoring system (AF-SCORE) predict fibrotic atrial myopathy and ablation success in patients with atrial fibrillation?
Population
958 patients with atrial fibrillation
Design
Cohort
Authors
Loading...
AF-SCORE may aid FAM risk stratification before PVI; hypothesis-generating and requires prospective validation before clinical use.
Observational (n=958)
1:1 to derivation or mapping-validation cohort
Yes
Can a simple clinical scoring system (AF-SCORE) predict fibrotic atrial myopathy and ablation success in patients with atrial fibrillation?
The AF-SCORE, a simple clinical tool based on age, sex, and AF persistency, can effectively predict the presence of fibrotic atrial myopathy and the success of pulmonary vein isolation in patients with atrial fibrillation.
Effect estimate: c-statistic 0.792
Müller‐Edenborn et al. (2021) conducted an observational in Atrial fibrillation (n=958). AF-SCORE (Age, sex, and AF-phenotype) vs. Low AF-SCORE was evaluated on Prediction of fibrotic atrial myopathy (FAM) in the external mapping-validation cohort (c-statistic 0.792).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: